PTOtherJournal of physical therapy science2019

Osteoporosis complication is a risk factor for frailty in females with type 2 diabetes mellitus.

Hiroshi Tamura, Toshiaki Miyamoto, Akira Tamaki and 2 others

PMID 31527997

WHAT IT FOUND

Frailty scores did not differ between older women with type 2 diabetes who had osteoporosis and those who did not.

In the osteoporosis group, weaker legs, grip and slower walking were linked with more frailty signs. Leg strength was lower than controls.

Key findings

01Frailty scale scores did not differ significantly between the osteoporosis and control groups (median 2 versus 1 points, p=0.92).

02Lower limb muscle strength was significantly lower in the osteoporosis group than in the control group (median 54.2 versus 83.4 Nm, p=0.03).

03In the osteoporosis group, frailty scores were inversely correlated with lower limb strength, handgrip and gait speed; no significant correlations were found in the control group.

STILL TO COME

How it was doneWhat they foundWhat it means for PTs

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

It was cross-sectional, so it cannot show that osteoporosis caused lower strength or frailty. The sample was small, with 27 older women with type 2 diabetes (14 with osteoporosis and 13 without). All participants were female, aged 65 years or older, and were in hospital for diabetes education. People with stroke, dementia or difficulty walking were excluded. Frailty scores did not differ between groups, while correlations were only within the osteoporosis group. The study did not test exercise or treatment.

Declared interests

The authors declared no conflicts of interest.

The easy way to misread this

Do not conclude that osteoporosis causes frailty or that leg-strength exercise will improve frailty. Frailty scores did not differ between groups, and this was a small cross-sectional study of 27 older women with type 2 diabetes, not a treatment trial.

Read it on PubMed →